LATANOPROST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Latanoprost, and what generic alternatives are available?
Latanoprost is a drug marketed by Amring Pharms, Apotex Inc, Bausch And Lomb, Epic Pharma Llc, Eugia Pharma, Fdc Ltd, Ryan Labs, Sandoz, and Somerset. and is included in nine NDAs.
The generic ingredient in LATANOPROST is latanoprost. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the latanoprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Latanoprost
A generic version of LATANOPROST was approved as latanoprost by AMRING PHARMS on March 22nd, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LATANOPROST?
- What are the global sales for LATANOPROST?
- What is Average Wholesale Price for LATANOPROST?
Summary for LATANOPROST
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 191 |
| Patent Applications: | 6,239 |
| Drug Prices: | Drug price information for LATANOPROST |
| Drug Sales Revenues: | Drug sales revenues for LATANOPROST |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for LATANOPROST |
| What excipients (inactive ingredients) are in LATANOPROST? | LATANOPROST excipients list |
| DailyMed Link: | LATANOPROST at DailyMed |
See drug prices for LATANOPROST
Recent Clinical Trials for LATANOPROST
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| DataPharm Australia, CMAX Clinical Research, Agilex Australia | Phase 1 |
| Aneira Pharma, Inc. | Phase 1 |
| Peregrine Ophthalmic | Phase 1 |
Pharmacology for LATANOPROST
| Drug Class | Prostaglandin Analog |
Anatomical Therapeutic Chemical (ATC) Classes for LATANOPROST
US Patents and Regulatory Information for LATANOPROST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amring Pharms | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 200925-001 | Mar 22, 2011 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ryan Labs | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 202077-001 | Feb 11, 2013 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Epic Pharma Llc | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 090887-001 | Jul 19, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 091449-001 | Mar 22, 2011 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Apotex Inc | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 077697-001 | Mar 22, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 201006-001 | Mar 22, 2011 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
